598 related articles for article (PubMed ID: 28039691)
1. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
[TBL] [Abstract][Full Text] [Related]
2. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
3. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
4. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
5. Integrating virtual screening and combinatorial chemistry for accelerated drug discovery.
López-Vallejo F; Caulfield T; Martínez-Mayorga K; Giulianotti MA; Nefzi A; Houghten RA; Medina-Franco JL
Comb Chem High Throughput Screen; 2011 Jul; 14(6):475-87. PubMed ID: 21521151
[TBL] [Abstract][Full Text] [Related]
6. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
7. Computational Studies in Drug Design Against Cancer.
De B; Bhandari K; Mendonça FJB; Scotti MT; Scotti L
Anticancer Agents Med Chem; 2019; 19(5):587-591. PubMed ID: 30207247
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
9. Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches.
Basith S; Cui M; Macalino SJY; Choi S
Curr Med Chem; 2017; 24(42):4753-4778. PubMed ID: 27593958
[TBL] [Abstract][Full Text] [Related]
10. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
[TBL] [Abstract][Full Text] [Related]
11. Virtual compound screening in drug discovery.
Stumpfe D; Ripphausen P; Bajorath J
Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
13. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
Guedes RA; Serra P; Salvador JA; Guedes RC
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
[TBL] [Abstract][Full Text] [Related]
14. Computational approaches to structure-based ligand design.
Joseph-McCarthy D
Pharmacol Ther; 1999 Nov; 84(2):179-91. PubMed ID: 10596905
[TBL] [Abstract][Full Text] [Related]
15. A computer aided drug discovery based discovery of lead-like compounds against KDM5A for cancers using pharmacophore modeling and high-throughput virtual screening.
Tariq A; Rehman HM; Mateen RM; Ali M; Mutahir Z; Afzal MS; Sajjad M; Gul R; Saleem M
Proteins; 2022 Mar; 90(3):645-657. PubMed ID: 34642975
[TBL] [Abstract][Full Text] [Related]
16. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
17. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
18. Designing multi-targeted agents: An emerging anticancer drug discovery paradigm.
Fu RG; Sun Y; Sheng WB; Liao DF
Eur J Med Chem; 2017 Aug; 136():195-211. PubMed ID: 28494256
[TBL] [Abstract][Full Text] [Related]
19. Strategy of computer-aided drug design.
Veselovsky AV; Ivanov AS
Curr Drug Targets Infect Disord; 2003 Mar; 3(1):33-40. PubMed ID: 12570731
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
Kumalo HM; Bhakat S; Soliman ME
Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
